Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
Alvotech Announces Webcast of First Quarter 2024 Financial Results on May 22, 2024, at 8:00 am EDT (12 noon GMT)
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Alvotech Announces Participation at BofA Securities Healthcare Conference 2024
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
AbbVie stock slides 6% amid concerns about falling Humira sales
AbbVie stock slides 6% amid concerns about falling Humira sales
Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed Biosimilar for Simponi® (golimumab)
Analysts Are Bullish on These Healthcare Stocks: Alvotech (ALVO), Cardinal Health (CAH)
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.